Tropical parasitic nephropathies

Nephrology Dialysis Transplantation

Volumn 14, Issue SUPPL. 3, 1999, Pages 79-91

  Barsoum, Rashad ^a,b  

^a CAIRO UNIVERSITY   (Egypt)

^b Cairo Kidney Center   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE KIDNEY TUBULE NECROSIS; CLINICAL FEATURE; CONFERENCE PAPER; DISEASE TRANSMISSION; ECHINOCOCCOSIS; FILARIASIS; GLOMERULONEPHRITIS; HUMAN; IMMUNE RESPONSE; KIDNEY AMYLOIDOSIS; KIDNEY DISEASE; KIDNEY FAILURE; MALARIA FALCIPARUM; OPPORTUNISTIC INFECTION; PARASITOSIS; PRIORITY JOURNAL; SCHISTOSOMIASIS;

EID: 0033049091     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/14.suppl_3.79     Document Type: Conference Paper

References (104)

1. Crawford FG, Vermund SH. Human cryptosporidosis. CRC Crit Rev Microbiol 1988; 16: 113-117
2. Renoult E, Georges E, Biava MF et al. Toxoplasmosis in kidney transplant recipients: a life-threatening but treatable disease. Transplant Proc 1997; 29: 821-822
3. Portoles J, Prats D, Torralbo A, Herrero JA, Torrente J, Barrientos AA. Visceral leishmaniasis: a cause of opportunistic infection in renal transplant patients in endemic areas. Transplant 1994; 57: 1677-1679
4. Lopez Blanco OA, Cavalli NH, Jasovich A, Gotleib D, Gonzalez-Cappa S. Chagas' disease and kidney transplantation-follow-up of nine patients for 11 years. Transplant Proc 1992; 24: 3089-3090
5. DeVault GA Jr, King JW, Rohr MS, Landreneau MD, Brown ST 3rd, McDonald JC. Opportunistic infection with Strongyloides stercoralis in renal transplantation. Rev Infect Dis 1990; 12: 653-671
6. Sever MS, Ecder T, Aydin AE et al. Living unrelated (paid) kidney transplantation in Third-World countries: high risk of complications besides the ethical problem. Nephrol Dial Transplant 1994; 9: 350-354
7. Azevedo LS, de Paula FJ, Ianhez LE, Saldanha LB, Sabbaga E. Renal transplantation and schistosomiasis mansoni. Transplantation 1987; 44: 795-798
8. Olivares Fontt E, Heirman C, Thielemans K, Vary B. Granulocyte-macrophage colony-stimulating factor: involvement in control of Trypanosoma cruzi infection in mice. Infect Immun 1966; 64: 3429-3434
9. Prina E, Lang T, Glaichenhaus N, Antoine JC. Presentation of the protective parasite antigen LACK by Leishmania-infected macrophages. J Immunol 1996; 156: 4318-4327
10. Sobh M, Moustafa F, Hamid S, Ghoneim M. Schistosomal-specific nephropathy in Syrian golden hamsters: treatment by induction of antigen excess. Nephrol Dial Transplant 1996; 11: 2178-2184
11. Persat F, Vincent C, Schmitt D, Mojon M. Inhibition of human peripheral blood mononuclear cell proliferative response by glycosphingolipids from metacestodes of Echinococcum multilocularis. Infect Immun 1996; 64: 3682-3687
12. King CL, Medhat A, Malhorta I et al. Cytokine control of parasite-specific anaergy in human urinary schistosomiasis. IL-10 modulates lymphocyte reactivity. J Immunol 1996; 156: 4715-4721
13. Sitprija V, Benyajati C. Tropical diseases and acute renal failure. Ann Acad Med Singapore 1975; [Suppl] 4: 112-124
14. Editorial. The nephrotic syndrome in the tropics. Lancet 1980; 2: 461-463
15. Edelstein L. The genuine works of Hippocrates. Bull Inst Hist Med 1939; 7: 236-248
16. Atkinson LE. Bright's disease of Malarial origin. Am J Med Sci 1884; 88: 149-163
17. Giglioli G. Malarial Nephritis: Epidemiological and Clinical Notes on Malaria. Blackwater Fever, Aluminuria and Nephritis in the Interior of British Guiana, Based on Seven Year's Continual Observation. Churchill, London: 1930
18. Gilles HM, Hendrichse RG. Nephrosis in Nigerian children. Role of malaria and effect of antimalarial treatment. Br Med J (Clin Res) 1963; 2: 27-43
19. Hendrickse RG. Epidemiology and prevention of kidney disease in Africa. Trans R Soc Trop Med Hyg 1980; 74: 8-16
20. Barsoum RS. Schistosomal glomerulopathies. Kidney Int 1993; 44: 1-12
21. El-Said W, Barakat S, Khedr E et al. Complications of schistosomiasis among Egyptian dialysis patients [Abstract]. II International Congress of Geographical Nephrology, Hurghada, Egypt: 1993: 40
22. Brito T, Gunji J, Camargo ME et al. Advanced kidney disease in patients with hepatosplenic Manson's schistosomiasis. Rev Inst Med Trop Sao Paulo 1970; 12: 225-234
23. Sobh MA, Moustafa FE, el-Housseini F, Basta MT, Deelder AM, Ghoniem MA. Schistosomal specific nephropathy leading to end-stage renal failure. Kidney Int 1987; 31: 1006-1011
24. Sitprija V. Nephrology forum: nephropathy in falciparum malaria. Kidney Int 1988; 34: 867-877
25. Kilejian A, Abati A, Trager W. Plasmodium falciparum and Plasmodium coatney: immunogenicity of knob-like protrusions on infected erythrocyte membrane. Exp Parasitol 1977; 42: 157-162
26. Kojima S. Molecular biology of malaria. XIV International Congress of Nephrology. Sydney: 1997: S5
27. Facer CA, Theodoridou A. Elevated plasma levels of P-selectin (GMP-140/CD62P) in patients with Plasmodium falciparum malaria. Microbiol Immunol 1994; 38: 727-731
28. Graninger W, Prada J, Neifer S, Zotter G, Thalhammer F, Kremsner PG. Upregulation of ICAM-I by Plasmodium falciparum: in vitro and in vivo studies. J Clin Pathol 1994; 47: 653-656
29. Clark IA. Suggested importance of monokines in pathophysiology of endotoxin shock and malaria. Klin Wochenschr 1982; 60: 756-758
30. Barsoum RS. Malarial nephropathies. Nephrol Dial Transplant 1998; 13: 1588-1597
31. Ruebush TK 2nd, Juranek DD, Spielman A, Piesman J, Healy GR. Human babesiosis on Nantucket Island. Am J Trop Med Hyg 1981; 30: 937-941
32. Hicks RV, James C, Webbe G. Effect of Schistosoma haematobium and N-butyl-N-14-hydroxybutylnitrosamine on the development of urothelial neoplasia in the baboon. Br J Cancer 1980; 42: 730-755
33. Badr MM. Surgical management of urinary bilharziasis. In: Dudley H, Porres WJ, Carter DC, Mc Douglas WS, eds. Rob and Smith's Operative Surgery. Butterworth, London: 1986
34. Rosin MP, Anwar WAA, Ward AJ. Inflammation, chromosomal instability, and cancer: the schistosomiasis model. Cancer Res 1994; 54 [Suppl 7]: 1929s-1933s
35. Habuchi T, Takahashi R, Yamada H et al. Influence of cigarette smoking and schistosomiasis on p53 gene mutation in urothelial cancer. Cancer Res 1993; 53: 3795-3799
36. Beyribey S, Cetinkaya M, Adsan O, Coskun F, Ozturk B. Treatment of renal hydatid disease by pedicled omentoplasty. J Urol 1995; 154: 25-27
37. Addiss DG, Dimock KA, Eberhard ML, Lammie PJ. Clinical, parasitologic and immunologic observations of patients with hydrocele and elephantiasis in an area with endemic lymphatic filariasis. J Infect Dis 1995; 171: 755-758
38. Roitt I, Brostoff J, Male D. Immunity to protozoa and worms. In: Roitt IM, Brostoff J, Male DK, eds. Immunology. Churchill Livingstone, Edinburgh: 1985
39. Boros DL. Immunopathology of Schistosoma mansoni infection. Microbiol Rev 1989; 2: 250-258
40. 2 cytokine in murine schistosomiasis mansoni. J Immunol 1991; 146: 1322-1328
41. McLaren DJ, Terry RJ. The protective role of acquired host antigens during schistosome maturation. Parasite Immunol 1982; 4: 129-148
42. Sobh M, Moustafa F, Hamid S, Ghoneim M. Schistosomal-specific nephropathy in Syrian golden hamsters: treatment by induction of antigen excess. Nephrol Dial Transplant 1996; 11: 2178-2184
43. Sobh M, Moustafa F, El-Arbagy A, Shehab El-Din M. Nephropathy in asymptomatic patients with active Schistosoma mansoni infection. Int Urol Nephrol 1990; 22: 37-43
44. Chandra-Shekkar K, Pathmanathan R. Schistosomiasis in Malaysia. Rev Infect Dis 1987; 9: 1026-37
45. Hendrickse RG, Adeniyi A. Quartan malarial nephrotic syndrome in children. Kidney Int 1979; 16: 64-74
46. Waugh DA, Alexander JH, Ibels LH. Filarial chyluria-associated glomerulonephritis and therapeutic consideration in the chyluric patient. Aust N Z J Med 1980; 10: 559-62
47. Ayachi R, Ben Dhia N, Guediche N et al. The nephrotic syndrome in kala-azar. Arch Fr Pediatr 1988; 45: 493-495
48. Sitprija V, Keoplung M, Boonpucknavig V, Boonpucknavig S. Renal involvement in human trichinosis. Arch Intern Med 1980; 140: 544-546
49. Okelo GBA, Kyobe J. A three-year review of human hydatid disease seen at Kenyata National Hospital. East Afr Med J 1981; 58: 695-701
50. Ginsburg BE, Wasserman J, Huldt G, Bergstrand A. A case of glomerulonephrits associated with acute toxoplasmosis. Br Med J 1974; 3: 664-665
51. Lindsley HB, Nagle RB, Werner PA, Stechschulte DJ. Variable severity of glomerulonephritis in inbred rats infected with Trypanosoma rhodesiense. Correlation with immunoglobulin class-specific antibody responses to trypanosomal antigens and total IgM levels. Am J Trop Med Hyg 1980; 29: 348-357
52. Futrakul P, Boonpucknavig V, Boonpucknavig S, Mitrakul C, Bhamarapravati N. Acute glomerulonephritis complicating Plasmodiumfalciparum infection. Clin Pediatr 1974; 13: 281-283
53. Ezzat E, Osman R, Ahmed KY, Soothill JF. The association between Schistosoma haematobium infection and heavy proteinuria. Trans R Soc Trop Med Hyg 1974; 68: 315-318
54. Murray HW, Rubin BY, Carriero SM, Harris AM, Jaffee EA. Human mononuclear phagocyte antiprotozoal mechanisms: oxygen-dependent vs oxygen-independent activity against intracellular Toxoplasma gondii. J Immunol 1985; 134: 1982-1988
55. Caravaca F, Munoz A, Pizarro JL, Saez de Santamaria J, Fernandez-Alonso J. Acute renal failure in visceral leishmaniasis. Am J Nephrol 1991; 11: 350-352
56. Karp CL, El-Safi SH, Wynn TA et al. In vivo cytokine profiles in patients with kala-azar. Marked elevation of interleukin-10 and interferon-gamma. J Clin Invest 1993; 91: 1644-1648
57. Holaday BJ, Pompeu MM, Jeronimo S et al. Potential role for interleukin-10 in the immunosuppression associated with kala azar. J Clin Invest 1993; 92: 2626-2632
58. Dutra M, Martinelli R, de Carvalho EM, Rodrigues E, Brito E, Rocha H. Renal involvement in visceral leishmaniasis. Am J Kidney Dis 1985; 6: 22-27
59. Caravaca F, Munoz A, Pizarro JL, Saez de Santamaria J, Fernandez-Alonso J. Acute renal failure in visceral leishmaniasis. Am J Nephrol 1991; 11: 350-352
60. Cheever AW. Schistosoma japonicum: the pathology of experimental infection. Exp Parasitol 1985; 59: 1-11
61. Robinson A, Lewert RM, Spargo BH. Immune complex glomerulonephritis and amyloidosis in Schistosoma japonicum infected rabbits. Trans R Soc Trop Med Hyg 1982; 76: 214-226
62. Sobh M, Moustafa F, Ramzy R, Saad M, Deelder A, Ghoneim M. Schistosoma mansoni nephropathy in Syrian golden hamsters. Effect of dose and duration of infection. Nephron 1991; 59: 121-130
63. Crowell WA, Votava CI. Amyloidosis induced in hamsters by a filarid parasite (Dipetalonema vitae). Vet Pathol 1975; 12: 178-185
64. Veress B, Abdalla RE, El Hassan AM. Electron microscope investigations on leishmaniasis in the Sudan. I. Morphometric studies on Leishmania amastigotes in various forms of human leishmaniasis. Ann Trop Med Parasitol 1980; 74: 421-426
65. Ali-Khan Z, Sipe JD, Du T, Riml H. Echinococcus multilocularis: relationship between persistent inflammation, serum amyloid A protein response and amyloidosis in four mouse strains. Exp Parasitol 1988; 67: 334-345
66. Barsoum RS, Bassily S, Soliman MM, Ramzy MF, Milad M, Hassaballa A. Renal amyloidosis and schistosomiasis. Trans R Soc Trop Med Hyg 1979; 73: 367-374
67. Omer HO, Wahab, SMA. Secondary amyloidosis due to schistosomiasis mansoni infection. Br Med J 1976; 1: 375-377
68. Smith JW, McDonald TL. Production of serum amyloid A and C-reactive protein by HepG2 cells stimulated with combinations of cytokines or monocyte conditioned media: the effects of prednisolone. Clin Exp Immunol 1992; 90: 293-299
69. Rokita H, Loose LD, Bartle LM, Sipe JD. Synergism of interleukin 1 and interleukin 6 induces serum amyloid A production while depressing fibrinogen: a quantitative analysis. J Rheumatol 1994; 21: 400-405
70. Luty AJ, Mackenzie CD, Moloney NA. Secondary amyloidosis in normal and immunocompromised mice infected with Schistosoma japonicum. Br J Exp Pathol 1987; 68: 825-838
71. + T cells. J Immunol 1996; 156: 1189-1195
72. Ray BK, Ray A. Involvement of an SAF-like transcription factor in the activation of serum amyloid A gene in monocyte/ macrophage cells by lipopolysaccharide. Biochemistry 1997; 36: 4662-4668
73. Houba V. Immunologic aspects of renal lesions associated with malaria. Kidney Int 1979; 16: 3-8
74. Felton SC, Hoffmann CC, Kreier JP, Glaser R. Hematologic and immunologic responses in common marmosets (Callithrix jacchus) infected with Plasmodium knowlesi and Epstein-Barr virus. Lab Anim Sci 1984; 34: 164-168
75. Wedderburn N, Davies DR, Mitchell GH, Desgranges C, de The G. Glomerulonephritis in common marmosets infected with Plasmodium brasilianum and Epstein Barr virus. J Infect Dis 1988; 158: 789-794
76. Izui S, Berney T, Shibata T, Fulpius T. IgG3 cryoglobulins in autoimmune MRL-Ipr/Ipr mice: immunopathogenesis, therapeutic approaches and relevance to similar human diseases. Ann Rheum Dis 1993; 52 [Suppl I]: S48-S54
77. Hunt JE, McNeil HP, Morgan GJ, Crameri RM, Krilis SA. A phospholipid beta 2-glycoprotein I complex is an antigen for anticardiolipin antibodies occurring in autoimmune disease but not with infection. Lupus 1992; 1: 75-81
78. Ngu JL, Chatelanat F, Leke R, Ndumbe P, Youmbissi J. Nephropathy in Cameroon: evidence for filarial derived immune complex pathogenesis in some cases. Clin Nephrol 1985; 24: 128-134
79. Ormerod AD, Petersen J, Hussey JK, Weir J, Edward N. Immune complex glomerulonephritis and chronic anerobic urinary tract infection; complication of filariasis. Postgrad Med J 1983; 59: 730-733
80. Chugh KS, Singhai PC, Tewari SC, Nath IV, Datta BN. Acute glomerulonephritis associated with filariasis. Am J Trop Med Hyg 1978; 27: 630-631
81. Date A, Gunasekaran V, Kirubakaran MG, Shastry JC. Acute eosinophilic glomerulonephritis with Bancroftian filariasis. Postgrad Med J 1979; 55: 905-907
82. Chavaz A, Mignon F, Morel-Maroger L, Richet G. Extramembranous glomerulitis. Apropos of 92 cases. Schweiz Med Wochenschr 1977; 107: 899-907
83. Thomas MA, Frampton G, Isenberg DA et al. A common anti-DNA antibody idiotype and anti-phospholipid antibodies in sera from patients with schistosomiasis and filariasis with and without nephritis. J Autoimmun 1989; 2: 803-811
84. Meilof JF, Van der Lelij A, Rokeach LA, Hoch SO, Smeenk RJ. Autoimmunity and filariasis. Autoantibodies against cytoplasmic cellular proteins in sera of patients with onchocerciasis. J Immunol 1993; 151: 5800-5809
85. Barsoum RS, Bassily S, Baligh O et al. Renal disease in hepatosplenic schistosomiasis: a clinicopathological study. Trans R Soc Trop Med Hyg 1977; 71: 387-391
86. Barsoum R. Schistosomal glomerulopathies. Kidney Int 1993; 44: 1-12
87. Hathout SE, El.Ghaffar, Awny AY. Chronic salmonellosis complicating schistosomiasis in Egypt. Am J Trop Med Hyg 1967; 16: 462-465
88. Lambertrucci JR, Godoy P, Neves J, Bambirra EA, Ferreira MD. Glomerulonephritis in Salmonella-Schistosoma mansoni association. Am J Trop Med Hyg 1988; 38: 97-102
89. Bassily S, Farid Z, Barsoum RS, Soliman LA, Higashi GI, Miner WF. Renal biopsy in Schistosoma-Salmonella associated nephrotic syndrome. J Trop Med Hyg 1976; 79: 256-258
90. Martinelli R, Pereira LJ, Rocha H. The influence of antiparasitic therapy on the course of glomerulopathy associated with schistosomaiasis mansoni. Clin Nephrol 1987; 27: 229-233
91. Sobh MA, Moustafa FE, Sally SM, Deelder AM, Ghoneim MA. Effect of antischistosomal treatment on schistosoma-specific nephropathy. Nephrol Dial Transplant 1988; 3: 744-751
92. Natali PG, Cioli D. Immune complex nephritis in Schistosoma mansoni-infected mice. Eur J Immunol 1976; 6: 359-364
93. van Marck EA, Decider AM, Gigase PL. Effect of partial portal vein ligation on immune glomerular deposits in Schistosoma mansoni-infected mice. Br J Exp Pathol 1977; 58: 412-417
94. Rocha H, Cruz T, Brito E, Susur M. Renal involvement in patients with hepatosplenic schistosomiasis mansoni. Am J Trop Med Hyg 1976; 25: 108-115
95. Andrade ZA, Andrade SG, Sadigursky M. Renal changes in patients with hepatosplenic schistosomiasis. Am J Trop Med Hyg 1971; 20: 77-83
96. Barsoum RS. Schistosomal glomerulopathy: selection factors. Nephrol Dial Transplant 1987; 2: 488-497
97. de Water R, Van Mark EA, Fransen JA, Deelder AM. Schistosoma mansoni: ultrastructural localization of the circulating anodic antigen and the circulating cathodic antigen in the mouse kidney glomerulus. Am J Trop Med Hyg 1989; 38: 118-124
98. Sobh MA, Moustafa FE, Sally SM, Deelder AM, Ghoniem MA. Characterization of kidney lesions in early schistosomal-specific nephropathy. Nephrol Dial Transplant 1988; 3: 392-398
99. Nabil M, Genin C, Francis M et al. Immunoglobulin pattern in schistosomal glomerulopathy (SG) - the significance of IgA (Abstract). II International Congress of Geographical Nephrology, Hughada, Egypt: 1993: 38
100. Barsoum RS, Nabil M, Saady G et al. Immunoglobulin A and the pathogenesis of schistosomal glomerulopathy. Kidney Int 1996; 50: 920-928
101. Abdel-Badie I. Thesis, Cairo University: 1997
102. Demaine AG, Rambausek M, Knight JF, Williams DG, Welsh KI, Ritz E. Relation of mesangial IgA glomerulonephritis to polymorphism of immunoglobulin heavy chain switch region. J Clin Invest 1988; 81: 611-614
103. Burdin N, Van Kooten C, Galibert L et al. Endogenous IL-6 and IL-10 contribute to the differentiation of CD40-activated human B-lymphocytes. J Immunol 1995; 154: 2533-2544
104. Hillyer GV. Deoxyribonucleic (DNA) and antibodies to DNA in the serum of hamsters and man infected with schistosomes. Proc Soc Exp Biol Med 1971; 136: 880-883